BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25244494)

  • 1. Long-term survival and late complications in intensity-modulated radiotherapy of locally recurrent T1 to T2 nasopharyngeal carcinoma.
    Tian YM; Guan Y; Xiao WW; Zeng L; Liu S; Lu TX; Zhao C; Han F
    Head Neck; 2016 Feb; 38(2):225-31. PubMed ID: 25244494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensity-modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma.
    Qiu S; Lin S; Tham IW; Pan J; Lu J; Lu JJ
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):676-83. PubMed ID: 22024207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone.
    Su SF; Han F; Zhao C; Chen CY; Xiao WW; Li JX; Lu TX
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):327-33. PubMed ID: 21035959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of total dose and fraction size on survival of patients with locally recurrent nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: a phase 2, single-center, randomized controlled trial.
    Tian YM; Zhao C; Guo Y; Huang Y; Huang SM; Deng XW; Lin CG; Lu TX; Han F
    Cancer; 2014 Nov; 120(22):3502-9. PubMed ID: 25056602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities.
    Sun X; Su S; Chen C; Han F; Zhao C; Xiao W; Deng X; Huang S; Lin C; Lu T
    Radiother Oncol; 2014 Mar; 110(3):398-403. PubMed ID: 24231245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and toxicities of intensity-modulated radiotherapy for patients with locally recurrent nasopharyngeal carcinoma.
    Chen HY; Ma XM; Ye M; Hou YL; Xie HY; Bai YR
    PLoS One; 2013; 8(9):e73918. PubMed ID: 24040115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advantages of intensity modulated radiotherapy in recurrent T1-2 nasopharyngeal carcinoma: a retrospective study.
    Qiu S; Lu J; Zheng W; Xu L; Lin S; Huang C; Xu Y; Huang L; Pan J
    BMC Cancer; 2014 Nov; 14():797. PubMed ID: 25366703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy.
    Hua YJ; Han F; Lu LX; Mai HQ; Guo X; Hong MH; Lu TX; Zhao C
    Eur J Cancer; 2012 Dec; 48(18):3422-8. PubMed ID: 22835782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
    Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy.
    Tian YM; Tian YH; Zeng L; Liu S; Guan Y; Lu TX; Han F
    Br J Cancer; 2014 Jan; 110(2):297-303. PubMed ID: 24335924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes and prognostic factors of re-irradiation for locally recurrent nasopharyngeal carcinoma using intensity-modulated radiotherapy.
    Han F; Zhao C; Huang SM; Lu LX; Huang Y; Deng XW; Mai WY; Teh BS; Butler EB; Lu TX
    Clin Oncol (R Coll Radiol); 2012 Oct; 24(8):569-76. PubMed ID: 22209574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma.
    Hwang JM; Fu KK; Phillips TL
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1099-111. PubMed ID: 9719121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?
    Teo PM; Kwan WH; Chan AT; Lee WY; King WW; Mok CO
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):897-913. PubMed ID: 9531376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The study of clinical long-term effect and prognostic factors in nasopharyngeal carcinoma after intensity modulated radiation therapy].
    Liu K; Han Y; Ma B
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 27(21):1177-83. PubMed ID: 24616996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and toxicities of intensity-modulated radiation therapy for patients with T4 nasopharyngeal carcinoma.
    Kong FF; Ying H; Du CR; Huang S; Zhou JJ; Hu CS
    PLoS One; 2014; 9(3):e91362. PubMed ID: 24608637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma.
    Peng G; Wang T; Yang KY; Zhang S; Zhang T; Li Q; Han J; Wu G
    Radiother Oncol; 2012 Sep; 104(3):286-93. PubMed ID: 22995588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic radiosurgery plus intracavitary irradiation in the salvage of nasopharyngeal carcinoma.
    Low JS; Chua ET; Gao F; Wee JT
    Head Neck; 2006 Apr; 28(4):321-9. PubMed ID: 16287135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal lobe injury after re-irradiation of locally recurrent nasopharyngeal carcinoma using intensity modulated radiotherapy: clinical characteristics and prognostic factors.
    Liu S; Lu T; Zhao C; Shen J; Tian Y; Guan Y; Zeng L; Xiao W; Huang S; Han F
    J Neurooncol; 2014 Sep; 119(2):421-8. PubMed ID: 24986091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-irradiation of nasopharyngeal carcinoma with intensity-modulated radiotherapy.
    Chua DT; Sham JS; Leung LH; Au GK
    Radiother Oncol; 2005 Dec; 77(3):290-4. PubMed ID: 16289398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity-modulated radiotherapy for stage IVA/IVB nasopharyngeal carcinoma: clinical outcomes and patterns of failure in an endemic area in China.
    Zeng L; Tian YM; Sun XM; Huang Y; Chen CY; Han F; Liu S; Lan M; Guan Y; Deng XW; Lu TX
    Strahlenther Onkol; 2014 Oct; 190(11):993-1000. PubMed ID: 24838409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.